Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03799419 · ClinicalTrials.gov registry record · NA
Cognitive Bias Modification for OCD
A NA study of Obsessive - Compulsive Disorder and Obsessive-compulsive Disorders and Symptoms, sponsored by Mclean Hospital.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT03799419: Completed NA study of Obsessive - Compulsive Disorder and Obsessive-compulsive Disorders and Symptoms, sponsored by Mclean Hospital.
NCT03799419 is a NA study of Obsessive - Compulsive Disorder and Obsessive-compulsive Disorders and Symptoms that has completed, run by Mclean Hospital. The registered enrollment target is 64 participants, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03799419, a NA study of Obsessive - Compulsive Disorder and Obsessive-compulsive Disorders and Symptoms, has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will conduct the development and preliminary evaluation of Cognitive Bias Modification for Interpretation (CBM-I) and Approach Avoidance Training (AAT) as augmentations to treatment as usual for OCD and related disorders. CBM-I refers to computerized interventions designed to directly manipulate interpretation bias through repeated practice on a training task, thereby inducing cognitive changes in a relatively automatic or implicit manner. In AAT, automatic approach tendencies toward feared stimuli are re-trained. Specifically, this study will examine the feasibility, acceptability, and clinical outcomes associated with CBM-I and AAT. Adults with obsessive compulsive disorder (OCD) and related disorders will be recruited from a treatment program for these disorders and participants will be randomly assigned to either receive: 1) eight sessions of CBM-I or eight sessions of psychoeducation as a control condition, or 2) AAT or eight sessions of an inactive (sham) version of the AAT training.
Primary Outcome
Measure of interpretation biases, specifically: Inflated Responsibility/Overestimation of Threat, Perfectionism/Intolerance of Uncertainty, and Importance/Control of Thoughts. 44-item self-report measure, items scored 1-7 and summed; greater scores indicate greater severity.
Conditions Studied
Interventions
- BEHAVIORAL Psychoeducation
- BEHAVIORAL Cognitive bias modification for interpretation bias
- BEHAVIORAL Approach avoidance training
- BEHAVIORAL Inactive sham approach avoidance training
Study Locations (1)
Massachusetts
- McLean Hospital - Belmont
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2024-07-23 |
| Phase | NA |
What the finished NCT03799419 record still lists
NCT03799419 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 4 interventions - of which Psychoeducation is the first listed.
NCT03799419 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03799419 about?
NCT03799419 is a clinical study titled "Cognitive Bias Modification for OCD". This study will conduct the development and preliminary evaluation of Cognitive Bias Modification for Interpretation (CBM-I) and Approach Avoidance Training (AAT) as augmentations to treatment as usual for OCD and related disorders. CBM-I refers to computerized interventions designed to directly man...
What is the current status of trial NCT03799419?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2019-04-01. Estimated completion is 2024-07-23.
What conditions does trial NCT03799419 study?
This clinical trial studies the following conditions: Obsessive - Compulsive Disorder, Obsessive-compulsive Disorders and Symptoms.
What interventions are being tested in trial NCT03799419?
The interventions under investigation include: Psychoeducation (BEHAVIORAL), Cognitive bias modification for interpretation bias (BEHAVIORAL), Approach avoidance training (BEHAVIORAL), Inactive sham approach avoidance training (BEHAVIORAL).
Who is sponsoring clinical trial NCT03799419?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03799419 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obsessive - Compulsive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03799419's enrollment target sits among peer trials
64 37th of 84 higher than 48 of 84 other Obsessive - Compulsive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obsessive - Compulsive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder
RECRUITING · NA
-
Mechanisms of Exposure Therapy for OCD
RECRUITING · NA
-
Using Personalized Assessments in the Treatment of Childhood OCD
RECRUITING · NA
-
Neural Mechanisms of Response Inhibition Training for OCRD
RECRUITING · NA
-
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
RECRUITING · NA
-
Interpretation Bias as a Mechanism of Treatment Response in OCD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI